systematic review. 17 No studies were excluded on the basis of age, sex, race, ethnicity or language spoken by the participants.
Intervention
Our conceptual definition of telehealthcare, as adapted from Miller, 18 is "the provision of personalized healthcare at a distance." This constitutes the following three factors: information obtained from the patient, whether by conversation, video, electrocardiography, oxygen saturation, etc., that details the patient's condition; electronic transfer of this information to a health care professional over a distance; and personalized feedback tailored to the patient and provided by a health care professional who exercises clinical skills and judgement.
"At a distance" refers to health care that uses a tool of distance communication that works without the simultaneous physical presence of the participants in the interaction. According to this definition, the technology used might be the tele phone, e-mail, the internet or any other networked or mobile device. The novelty or sophistication of the technology is irrelevant. Feedback from the health care professional to the patient could be synchronous or asynchronous (i.e., by store-and-forward technology, in which a patient's data are kept in an electronic repository and forwarded to a health care professional on request); we also stipulated that the health care pro fessional should provide advice tailored to the consulting patient.
Comparison
In most instances, telehealthcare was compared with face-to-face usual care. However, in some studies, the control arm also involved an increase in the frequency or intensity of contact between health care professionals and patients.
Outcomes
The outcomes studied included process measures and clinical parameters. The key outcomes included asthma-specific quality of life as measured by the Juniper scale, the risk of one or more visits to the emergency department for asthma over 12 months, and the number of patients with one or more admissions to hospital over 12 months.
Identifying studies for inclusion
We identified randomized controlled trials using the Cochrane Airways Group Specialised Register of Trials, which is derived from systematic searches of the following bibliographic databases: CENTRAL (the Cochrane Central Register of Controlled Trials), MEDLINE, Embase, CINAHL (Cumulative Index to Nursing and Allied Health Literature) and PsycINFO. Manual searches of respiratory journals and abstracts from meetings also contribute to the Cochrane Airways Group Specialised Register of Trials. All records in the register that had been coded as "asthma" were searched using the telehealthcare terms specified in Appendix 1 (available at www .cmaj .ca /lookup /suppl /doi :10 .1503 /cmaj .101146 / -/DC1).
Extraction and management of data
The following data were extracted from the included studies by one reviewer and independently checked by a second reviewer: country and setting; the design of the study; the number of participants, their mean ages and the range of ages; a description of the intervention being investigated and of how the control group was managed; measures of symptoms (see Table 1 and Appendix 2 [available at www .cmaj .ca /lookup /suppl /doi :10 .1503 /cmaj .101146 / -/DC1]); quality of life; use of the health care system, such as visits to the emergency department or admissions to hospital; cost data (from the perspective of the health care provider); monitoring of peak expiratory flow and patient diaries; patient's forced expiratory volume in one second and forced vital capacity; patient satisfaction; a description of adverse events; and patient withdrawal from the study.
Analysis
We assessed the risk of bias in each trial using the methods detailed in the Cochrane Handbook for Systematic Reviews of Interventions. 19 We calculated summary statistics for our primary outcomes. We calculated risk ratios (RRs) for the dichotomous variables; for the asthmarelated quality of life score, a continuous variable, we calculated mean differences. We used the authors' published data. To create forest plots, data had to be compatible across studies. For example, for quality of life, we included only studies that reported using the Juniper scale; for visits to the emergency department, we included only studies with results that could be summarized into the variable of the number of patients with one or more visits to the emergency department over 12 months of follow-up. In this way, we produced meaningful comparative data across studies. We also included raw data in our analyses where it was supplied to us by the authors. The data from all studies (i.e., whether it was possible to include these data in the meta-analysis or not) are summarized in Appendix 2, which provides an overview of the results from all of the eligible studies.
We assessed the statistical heterogeneity between studies and the likely impact of this heterogeneity on our meta-analysis using the I 2 statis- Telephone Symptoms (number of days patient had a wheeze in the last 3 mo), possession and use of a written action plan for asthma, use of preventive medication, patient's knowledge of asthma, parental quality of life, number of visits to family physician or specialist tic. 19 Where I 2 was 40% or less, we used a fixedeffect model. We used a random-effects model if the impact of the statistical heterogenity was high (i.e., I 2 > 40%). Pooled data were presented graphically with forest plots. We planned subgroup analyses according to the type of technology used for telehealthcare. We used funnel plots to assess possible bias in reporting and publication (data available upon request from the authors).
Results

Description of studies
Our searches identified 525 abstracts. Initially, 76 reports had seemed possibly relevant, but 21 trials (25 reports) were included after thorough full-text review. Appendix 1 details our search strategy, which is illustrated by a PRISMA flow chart in Figure 1 . A description of the studies we included is given in Table 1 . Two studies had to be translated from Japanese, and one study was translated from Italian. It was only possible to obtain partial translations of the Japanese reports. In addition, we found 14 ongoing trials that have reported preliminary findings in abstract form and 21 trials that have yet to report in any format.
Telehealthcare interventions studied
The most common model of intervention studied was an initial face-to-face introduction with follow-up exchanges between patient and health care professional using a telephone, the Internet or text messages. Seven studies applied this format. 20, 24, 27, 30, 31, 35, 42 Risk of bias in the included studies A summary of the risk of bias in the included studies can be seen in Appendix 3 (available at www .cmaj .ca /lookup /suppl /doi :10 .1503 /cmaj .101146 / -/DC1).
Effectiveness of telehealthcare
The impact of telehealthcare interventions on the quality of life of people with asthma was assessed in 14 trials. 22, 24, 26, 28, 29, 31, 32, 34, [38] [39] [40] [41] [42] 45 We did a metaanalysis of the nine studies that used Juniper's validated quality-of-life questionnaires (Figure 2A) . None of the studies that looked at quality of life reported a clinically important difference (i.e., a difference of more than 0.5 points on the Juniper questionnaire). Pooling the data from nine of these studies showed a statistically significant mean difference of 0.08 (95% CI 0.01 to 0.16).
Subgroup analyses were done for the telephone-only studies and for the studies looking at all other technologies. The five telephone-only studies pooled to give a mean difference of 0.04 (95% CI -0.05 to 0.12, Figure 2B ). The four studies looking at all other technologies pooled to give a greater mean difference of 0.21 (95% CI 0.07 to 0.34, Figure 2C ); however, this difference is still less than the minimum clinically significant difference.
Ten studies (published in 11 reports) reported data on visits to the emer gency department. 22, 24, 27, 30, 32, 34, 36, 39, 41, 42, 46 The effect of telehealthcare interventions on the number of patients with one or more visits to the emergency department over 12 months is shown in Figure 3 . This meta-analysis included five trials representing 619 patients. 22, 27, 34, 39, 42 It revealed a nonsignificant increase in RR of one or more visits to the emer- Six studies presented data on admissions to hospital. 22, 28, 30, 34, 35, 39 For two studies, 30, 35 these admissions occurred over three months. For the remaining four studies, admissions to hospital were recorded as having occurred over 12 months.
For the two studies that provided data on outcomes at three months, meta-analysis showed high heterogeneity (I 2 = 78%), so the analysis was done using random effects (RR 0.91 [95% CI 0.07 to 12.69], Figure 4A ). The confidence intervals were very wide, suggesting that it is difficult to draw any firm conclusion regarding the risk of admission to hospital over three months in the telehealthcare group versus the control group.
Meta-analysis of the four studies that reported the number of patients admitted to hospital once or more within 12 months of randomization is shown in Figure 4B ( The results of studies examining symptoms as an outcome are summarized in the Table of Results in Appendix 2. The results suggest that symptom scores may be improved with telehealthcare. However, in many instances, there was no difference between groups.
Secondary outcomes: adverse events
There were few adverse events reported in the studies. Two people with asthma died during the intervention arm of one study, 29 but correspondence with the study's authors confirmed that these deaths were not related to asthma. This is important, as it may be expected that if telehealthcare is used as a substitute for face-to-face care, then a reduction in the intensity of health care may place a patient at risk. Larger studies are required to address this concern more fully.
Interpretation
Main findings
Our meta-analyses of the published trial evidence failed to show an appreciable impact of telehealthcare on disease-specific quality of life or risk of attendance at the emergency department 
Study or subgroup
Chan 2007 22 Donald 2008 27 Kokubu 2000 34 Rasmussen 2005 for people with asthma. However, meta-analysis did show that telehealthcare may result in a reduction in the risk of admission to hospital for asthma, particularly among people at high risk.
Explanation and comparison with other studies
In contrast to our findings, a review by Duvvuri concluded that information and communication technologies can have a major role in helping a much broader section of the population of people with asthma. 47 The inclusion criteria of that review were broader than ours, in that the authors searched for decision support and tools of patient education in addition to the technologies in which we were interested. Studies were summarized in narrative form and no meta-analyses were attempted. Duvvuri and colleagues also drew attention to some favourable analyses of cost effectiveness and patient satisfaction. In addition, they identified the remaining hurdle of physician licensing and re imbursement when care is delivered via tele healthcare. This is particularly an issue in countries where physicians claim a fee for service from a health insurance provider, such as in Canada and the United States. We would be more cautious in recommending rapid adoption and implementation of telehealthcare strategies without further evaluation.
Limitations
The first limitation to consider is our definition of telehealthcare. Our definition rules out several interventions that others may argue do constitute telehealthcare because it stipulates that a health care professional must be actively involved with the ongoing delivery of the intervention. Our definition excluded technologies for self care and self education and websites.
Our definition also included basic technologies, particularly the telephone. We justify the telephone as a legitimate form of telehealthcare because it very effectively enables personalized health care over a distance, and it has been included in many programs of telehealthcare. Telehealthcare does not have to be new, novel or sophisticated, and the telephone is a legitimate and well-researched medium for providing telehealthcare.
In general, the level of intervention may vary in telehealthcare, with tasks delegated to less senior, less expensive health care professionals and to patients themselves for self-care when their asthma is stable. This variation may lead to more effectively tailored care. For example, telehealthcare can be supported by computer algorithms when asthma is well controlled, or it can involve more sophisticated telemonitoring when a patient's condition is less stable (i.e., "hospital at home" monitoring). The benefits of telehealthcare are mediated by education, an enhanced therapeutic relationship, more intensive monitoring of the patient and feedback. The precise mixture of these elements has not been measured by the different studies in this review; however, these elements are important and they should be studied further as per the research framework for complex interventions of the United Kingdom's Medical Research Council. 48 Only four studies could be included to assess the effect of telehealthcare on admission to hospital. This is either because the other studies were too small or the follow-up period was too short to include patients who were admitted to hospital, or because the studies included only patients with mild asthma and there were no admissions to hospital. Because a large number of different scales for symptoms were used, meta-analysis across studies was not done for this outcome. Likert-type patient-satisfaction scores were reported in a number of studies and generally re flected a high level of satisfaction. However, the disadvantage of such scales is that detailed information is not gathered because of the limitations of a longitudinal scale. Complementing this type of literature with future qualitative research will help us to understand what has been missed in terms of value from the perspective of the patients and that of physicians who deal with the less severe end of the spectrum of asthma.
Conclusions and implications for further research
Telehealthcare is no worse than normal care in its ability to improve quality of life in carefully selected and triaged patients receiving primary and secondary care. It does not appear more able to improve quality of life than routine models of care, nor does it appear to reduce the number of visits a patient makes to the emergency department. Studies with larger intervention and control groups are needed to confirm these results with precision. We did, however, find that admissions to hospital decreased. It may be useful to consider focusing certain telehealthcare interventions on groups with higher risk. Further research should look at stratifying the risk of admission to hospital and relating it to the effectiveness of telehealthcare intervention.
Many of the patients in the control arms of the studies received enhanced face-to-face care for their asthma rather than usual care, so it was particularly challenging to show the benefits of telehealthcare in these comparisons. Future studies should make comparisons with usual care to best judge whether telehealthcare offers any improvement, or equivalence studies should be done if Research the population in the control group receives enhanced care. Considerably more research is also needed to investigate the cost effectiveness of telehealthcare-centred models of care.
